CAR-T Therapies for T Cell Malignancies
Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only! Grab it Explore the cutting-edge world of CAR-T therapies for T cell malignancies in this keynote presentation from the 2023 Cancer Genomics Consortium Annual Meeting. Delivered by John DiPersio and introduced by Obi Griffith, this 51-minute talk delves into the latest advancements in cancer treatment. Gain insights into how chimeric antigen receptor T-cell therapy is revolutionizing the approach to T cell malignancies. Learn about the Cancer Genomics Consortium's mission to promote best practices in clinical cancer genomics and their goal of ensuring accurate genomic diagnoses for all cancer patients. Discover how this organization strives to be the authoritative voice in clinical cancer genomic testing guidance.